15 February 2016 – Chinese new year, fintech investor BBVA, Innogy Venture Capital, triple French biotech fund, Unicef, Shanghai reimburses venture capital firms and more

Funds

Financial services provider BBVA has been a notable fintech investor since early 2013 when it formed a $100m fund that has since backed companies including DocuSign, Taulia and Prosper. The bank has now elected to upgrade its participation, committing another $150m and spinning out its investments into a new VC firm called Propel Venture Partners. Propel is already operational in San Francisco and is actively recruiting for a London office.

RWE’s Innogy Venture Capital may have been quiet of late but that doesn’t mean the utility has given up on corporate venturing. Chief executive Peter Terium reiterated its commitment to innovation on Friday and revealed plans for another investment unit which will be sized at $145m.

In addition to that fund, RWE is also set to invest $15m in a so far unnamed greentech-focused venture capital fund.

France triples its biotech fund.

Unicef’s $9m Innovation Fund opens for expressions of interest from entrepreneurs, inventors and companies with working prototypes of open source technology that can improve the lives of vulnerable children.

The government of Shanghai’s plans to compensate venture capital firms that fail to make back their initial investment in startups has drawn criticism.

Investments

Uber has targeted $2.1bn in new equity funding at a jawdropping $62.5bn valuation in spite of a fundraising climate generally agreed to be cooling. Today it came a step closer, raising $200m from investment firm LetterOne, which joins a range of backers including corporates Alphabet, Baidu, Times Group, Ping An and China Life Insurance.

One of the biggest areas for VC funding last year was India’s e-commerce sector, and One97 Communications was one of the biggest recipients, securing $680m from Alibaba and Ant Financial. One97 is now looking to raise another $400m by the end of June to fund the spinning out of its flagship brand, Paytm, into a separate mobile banking and payment company.

A possible partnership with e-commerce marketplace Flipkart could also be on the cards. Africa Internet Group (AIG), the collection of African businesses overseen by Rocket Internet that is also backed by telecom companies MTN and Millicom, has welcomed a new backer. AXA paid $83m for an 8% stake in AIG as part of a strategic partnership that will allow it to sell insurance products through AIG’s companies, and in particular e-commerce marketplace Jumia.

Cambridge University breaks its own seed funding record for the third year in a row, investing $5.5m last year.

Exits

Proteostasis raised $50m (see below) while AveXis secured $95m, floating in the middle of its $19 to $21 range. AveXis, which is backed by Roche’s corporate venturing fund, will use the proceeds to steer its lead candidate, a gene therapy treatment for spinal muscular atrophy, through phase 1 trials.

Good analysis recommendation: Bruce Booth at Life Sci VC 

“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

8 February 2016 – Munce retires, Jasper exit, Sesame Street, Pierre Fabre and more…

Big news – people moves

Claudia Fan Munce’s retirement as managing director of IBM’s Venture Capital Group, following other high-profile departures such as Nagraj Kashyap and Arvind Sodhani over the past year.

Tom Hockaday leaving Isis.

Exits

Jasper (Singtel and Temasek) after Gilt last month.

Rocket Internet has sold its food ordering sites in Europe, Mexia and Brazil to Just Eat, a London-based competitor, for $140 million.

IPOs

China-based, Merck & Co-backed immuno-oncology drug developer BeiGene floated on Nasdaq yesterday in a $158m IPO, the same day as genome editing company Editas Medicine.

Editas is also trading up, and it wouldn’t be a surprise to see several more IPOs before the end of February.

But doubt it’ll be UBER, despite Fred Wilson’s demands as a non-shareholder.

Fundraising

Sesame Street’s new fund

Pierre Fabre, the 2nd largest French independent pharmaceutical group, have launched Pierre Fabre Fund for Innovation.

Two weeks ago, GlaxoSmithKline and Johnson & Johnson were among the founders of the UK-based Apollo Therapeutics Fund, and they’ve teamed up again as limited partners in the $230m first fund closed by Medicxis Ventures, a life sciences-focused firm spun out of venture firm Index Ventures. GSK and Johnson & Johnson were previously LPs in Medicxis’ predecessor, the first life sciences fund raised by Index, in 2012.
Plus debuts slow, although Luma has two intel capital veterans.

Kuwait potentially throwing $100bn at its sovereign wealth fund.